Ambuja Cements Limited (AMBUJACEM) — Corporate Action | 26 August 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Ambuja Cements to merge with Orient Cement via shareholder-approved scheme
🔄 What Changed
Approval of amalgamation scheme via e-voting; remote meeting format; quorum and voting thresholds defined
🔮 What's Next
NCLT petition filing scheduled; shareholder approval required before scheme implementation
💡 Investor Takeaway
Shareholders must vote remotely to approve the merger, which will consolidate ownership and create a larger cement entity.

Ambuja Cements Limited announced a shareholders' meeting on September 28, 2026, to approve the amalgamation of Orient Cement Limited with itself. The meeting will be conducted via video conferencing with remote e-voting available from September 23 to 27, 2026, and a cut-off date for e-voting on September 21, 2026. Shareholders must vote through CDSL or NSDL platforms, with specific login requirements for demat and physical shareholders. Quorum requires 30 equity shareholders, and approval needs a majority representing three-fourths in value of voting shares. The scheme requires NCLT approval, and results will be published on the company's website and CDSL platform.

📄 View Original Announcement (PDF)

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement · Listed on NSE

Market Cap: ₹1,00,063.59 Cr P/E: 22.6 ROE: 8.8% ROCE: 4.9% Div Yield: 0.50%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AMBUJACEM — Free

Free account · 2 AI queries/day